Physician profile
Angela Stack Harris
NPI 1013992668
$4,245.04
in general payments reported to CMS, 2019-2025
18 companies · $2,452 in 2025
The $2,452 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $266 · 2021: $121 · 2022: $351 · 2023: $281 · 2024: $560 · 2025: $2,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165 · Travel and Lodging: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,164.70 |
| Travel and Lodging | $1,127.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,191.55 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $821.83 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Sun Pharmaceutical Industries INC. | $350.37 | 2020-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $249.30 | 2022-2024 | Acuvue |
| Novartis Pharmaceuticals Corporation | $141.16 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $138.21 | 2023-2025 | Infuse, Miebo, Xiidra |
| Biotissue Holdings INC. | $62.59 | 2025 | |
| Kala Pharmaceuticals, INC. | $42.89 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.10 | 2019-2021 | |
| Harrow Eye, LLC | $32.53 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $25.00 | 2022 | |
| Heidelberg Engineering, INC. | $24.78 | 2022 | |
| Allergan, INC. | $23.76 | 2022 | |
| Thea Pharma INC. | $22.13 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $20.86 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $19.54 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $19.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.